Diploma (LON:DPLM) had its price target increased by Peel Hunt from GBX 1,400 ($18.29) to GBX 1,600 ($20.91) in a report released on Monday, ThisIsMoney.Co.Uk reports. They currently have an add rating on the stock.
Other research analysts have also recently issued research reports about the company. HSBC began coverage on Diploma in a research note on Tuesday, February 12th. They issued a hold rating and a GBX 1,325 ($17.31) price target on the stock. Berenberg Bank cut their price target on Diploma from GBX 1,435 ($18.75) to GBX 1,350 ($17.64) and set a hold rating on the stock in a research note on Tuesday, January 29th. Finally, Numis Securities reiterated a hold rating and issued a GBX 1,420 ($18.55) price target on shares of Diploma in a research note on Wednesday, March 27th. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of GBX 1,412.86 ($18.46).
Shares of DPLM opened at GBX 1,532 ($20.02) on Monday. The stock has a market cap of $1.73 billion and a price-to-earnings ratio of 32.18. Diploma has a 12 month low of GBX 1,144 ($14.95) and a 12 month high of GBX 1,654 ($21.61).
In other news, insider Johnny Thomson acquired 22,000 shares of the business’s stock in a transaction on Monday, February 25th. The shares were purchased at an average price of GBX 1,349 ($17.63) per share, for a total transaction of £296,780 ($387,795.64).
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery and minimally invasive surgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.
Read More: How Investors Use a Balance Sheet
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.